As quarantine orders are lifted and people start to resume their normal activities, Philips is focused on protecting community members who have leftover heart damage caused by COVID-19. Having a Philips HeartStart OnSite or HeartStart FRx AED on hand gives added peace of mind for people with compromised hearts.
With you every step of the way, Philips has been right here from the start in an effort to help healthcare workers on the frontlines treat patients with COVID-19. The Philips HeartStart OnSite and HeartStart FRx AEDs are with you every step of the way by guiding you through the process of treating a victim of suspected sudden cardiac arrest with real-time instructions, step-by-step voice commands, and CPR guidance.
With two-million AEDs sold around the world, Philips AEDs can be found on board major U.S. airlines, in Fortune 100 companies, and in the locker rooms of professional sports teams. Learn why Philips is the leader in AEDs and discover which AED is right for you.
Fill out a short form and an AED expert will reach out to you as soon as possible.
1. Three-quarters of adults with COVID-19 have heart damage after recovery https://www.sca-aware.org/sca-news/three-quarters-of-adults-with-covid-19-have-heart-damage-after-recovery 2. Twenty-one percent of ICU patients globally, hospitalized with COVID-19 had atrial fibrillation. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessmentcoronavirus-disease-2019-eighth-update-8-april-2020.pdf 3. ACC Clinical Guidance for the CV Care Team. https://www.acc.org/~/m edia/665AFA1E710B4B3293138D 14BE8D1213.pdf 4. Besides myocardial infarction and heart failure, arrhythmias are generally one of the three major risks associated with viral infections, due to myocarditis, proinflammatory effects, and an increased sympathetic stimulation. https://link.springer.com/article/10.1007/s00059-020-04924-0
General information
Emergency Care solutions
Audiences
You are about to visit a Philips global content page
Continue